This article does not endorse or promote the use of any pharmaceutical product outside its approved labeling or in a manner inconsistent with the advice of a licensed prescriber
Obesity is linked to at least 13 different cancers, including cancers of the breast, colon, liver and kidney
Recent studies have shown that GLP-1(936) is particularly effective at low glucose concentrations, with its inhibitory effect being similar to that of GLP-1(7-36)
They are also associated with lower risks of heart disease in people with obesity
Results GLP-1s reduce body weight by 518 % in trials, with modestly lower effects in real-world analyses, with multiple demonstrated clinical benefits
These medications have revolutionized weight management, with clinical studies showing patients losing 15-20% of their body weight on average after one year of treatment